Olympus Corp. (OTCMKTS:OCPNY) Lifted to “Buy” at Zacks Investment Research

Zacks Investment Research upgraded shares of Olympus Corp. (OTCMKTS:OCPNY) from a hold rating to a buy rating in a report released on Wednesday, October 18th. They currently have $40.00 price objective on the stock.

According to Zacks, “OLYMPUS CORPORATION is a Japan-based company. The Company is engaged in the manufacturing and selling of precision machineries and instruments. The businesses of the Company include Imaging System Business, Medical Systems Business, Life Science Business, Information and Communication Business, and Others Business. Olympus has always been a company that makes people’s dreams come true through innovative products. Olympus cameras have always been at the leading edge of innovation. “

Shares of Olympus Corp. (OTCMKTS OCPNY) traded up 1.11% during mid-day trading on Wednesday, reaching $36.75. 1,151 shares of the company’s stock traded hands. Olympus Corp. has a 12-month low of $33.17 and a 12-month high of $39.49. The company has a market cap of $12.58 billion, a P/E ratio of 17.09 and a beta of 1.11. The firm has a 50-day moving average of $34.83 and a 200 day moving average of $36.15.

TRADEMARK VIOLATION WARNING: “Olympus Corp. (OTCMKTS:OCPNY) Lifted to “Buy” at Zacks Investment Research” was reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this article on another domain, it was stolen and reposted in violation of United States and international trademark & copyright laws. The correct version of this article can be read at https://www.dispatchtribunal.com/2017/10/28/olympus-corp-ocpny-upgraded-to-buy-by-zacks-investment-research.html.

Olympus Corp. Company Profile

Olympus Corporation is engaged in the manufacture and sale of precision machineries and instruments. The Company’s segments include Medical Business, Scientific Solutions Business, Imaging Business and Others. The Company’s Medical Business manufactures and sells medical endoscopes, surgical endoscopes, endotherapy devices and other products.

Get a free copy of the Zacks research report on Olympus Corp. (OCPNY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Olympus Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olympus Corp. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply